Navigation Links
Global Call for Mercury-free Vaccines Issued
Date:3/15/2012

SILVER SPRING, Md., March 15, 2012 /PRNewswire-USNewswire/ -- In a historic open letter to the World Health Organization and other public health agencies, the Coalition for Mercury-Free Drugs (CoMeD), and the United Methodist Women are seeking to stop the use of mercury in human drugs, especially vaccines.  Currently, the mercury-based preservative Thimerosal, which is 49% mercury by weight, remains in vaccines for the United States and much of the world, despite the fact that it is a known neurotoxin.  While other safer and less toxic alternatives are being utilized, industry has been slow to eliminate Thimerosal from many vaccines, including the flu shot given to those most vulnerable to this toxin, children and pregnant women.

The goal of the United Methodist Women and CoMeD is to protect the global immunization program and to safeguard public confidence in vaccines by seeing that the addition of mercury to human pharmaceuticals ceases.  Through the ongoing diplomatic work of the Intergovernmental Negotiation Committee of the United Nations Environment Programme, these organizations hope to impact the formulation of a global, legally binding treaty on mercury scheduled to be completed in 2013.

In these negotiations, the World Health Organization and other global distributors of vaccines have defended the continuing use of mercury, especially in vaccines.  They maintain that there is no evidence of harm from Thimerosal.  Dr. Mark R. Geier, a CoMeD director, cautions, "Recent statements by those holding national and global responsibility for vaccine safety are difficult to reconcile with the known and published toxicity of Thimerosal."  Eight decades of scientific literature have shown that Thimerosal poses a significant health risk and its manufacturers acknowledge it can cause mild to severe mental retardation in children.

The United Methodist Church passed the first global resolution "Protecting Children from Mercury-containing Drugs," and the United Methodist Women have actively advocated for a ban of mercury in medicine on moral and ethical grounds.  As the Rev. Lisa K. Sykes, the author of the original draft of the United Methodist global resolution, asserts, "The United Methodist Women have historically advocated in the areas of education and health, both in this country and around the world. Undertaking the issue of mercury in vaccines and other drugs is just one expression of that commitment." 

The United Methodist Women and CoMeD support every effort to make safer vaccines, those without added mercury, equally available to all persons around the globe.


'/>"/>
SOURCE Coalition for Mercury-Free Drugs (CoMeD)
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
2. Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug
3. Directors Forum: PEPFAR and the Global AIDS Response
4. Alfacell Corporation to Present at UBS Global Life Sciences Conference
5. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
6. Global HIV Vaccine Enterprise Names Alan Bernstein as Inaugural Executive Director, Opens New Secretariat
7. President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its Stop Neglected Tropical Disease Campaign
8. Hillary Clinton Pledges Bold Approach to Stopping HIV/AIDS & Global Poverty
9. IBA and Elekta Initiate Global Particle Therapy Program at ASTRO
10. Dr. Rajeev Venkayya Joins Gates Foundation as Director of Global Health Delivery
11. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... , March 28, 2017  Medeon Biodesign, Inc., ... company, is pleased to announce that the Company ... of Panther Orthopedics, Inc., a San ... fixation solutions for orthopedic extremity applications.  ... expand rapidly, primarily due to procedure volume growth, ...
(Date:3/28/2017)... LONDON , March 28, 2017  "US ... insight on the various indicators and trend analysis ... generics drugs in mainstream pharmaceutical market in US. ... responsible for the growth on cancer generics drugs ... resulted in saving of billions of dollars for ...
(Date:3/28/2017)... 28, 2017  Orexigen Therapeutics, Inc. (Nasdaq: ... the fourth quarter and year ended December 31, 2016. ... transformational progress for Orexigen, beginning with the re-acquisition of ... early March, the team at Orexigen demonstrated remarkable focus, ... reshaped and strengthened our Company while rewarding us full ...
Breaking Medicine Technology:
(Date:3/28/2017)... NEW YORK (PRWEB) , ... March 28, 2017 ... ... development, NTX Technology™, is the first technology to directly address the resolution to ... Organization. NTX Technology™ is a patented compound of FDA and TTB approved ingredients ...
(Date:3/28/2017)... ... ... Dr. Isabella Wentz, PharmD, FASCP, one of the leading thyroid experts of ... Dr. Wentz talked about journey and research recently on a blog and discussed some ... only solution to deal with thyroid disease. , Dr. Wentz completed her graduation ...
(Date:3/28/2017)... ... March 28, 2017 , ... Alert Sentry Group LLC., a ... Personal Emergency Response Systems), the iSAFE and the iSAFE Plus. These iSAFE products are ... of their kind, the iSAFE and iSAFE Plus offer direct GPS Location and two-way ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... instruments are critical to ensuring high-quality results and maintaining GMP and USP compliance. ... Laboratory Instruments in accordance with GMP requirements " these requirements are explained. ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... corrosive ions found in power plant water and steam. , Chlorides and sulfates ... and boilers, leading to extensive maintenance and unplanned shutdowns. Monitoring these ions at ...
Breaking Medicine News(10 mins):